Timber Hill’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-7,700
Closed -$601K 2372
2016
Q2
$601K Sell
7,700
-37,600
-83% -$2.68M ﹤0.01% 1490
2016
Q1
$2.49M Buy
45,300
+26,000
+135% +$1.42M 0.01% 816
2015
Q4
$1.19M Sell
19,300
-32,700
-63% -$2.06M 0.01% 1247
2015
Q3
$3.28M Sell
52,000
-8,000
-13% -$571K 0.01% 747
2015
Q2
$4.38M Buy
60,000
+5,200
+9% +$376K 0.02% 647
2015
Q1
$3.58M Buy
54,800
+48,500
+770% +$3.22M 0.02% 743
2014
Q4
$410K Sell
6,300
-12,900
-67% -$831K ﹤0.01% 1990
2014
Q3
$1.15M Sell
19,200
-17,100
-47% -$1.12M ﹤0.01% 1494
2014
Q2
$2.51M Sell
36,300
-30,300
-45% -$1.96M 0.01% 1023
2014
Q1
$4.36M Buy
66,600
+15,000
+29% +$976K 0.02% 708
2013
Q4
$3.2M Sell
51,600
-39,500
-43% -$2.29M 0.01% 1042
2013
Q3
$4.89M Sell
91,100
-69,500
-43% -$3.58M 0.02% 860
2013
Q2
$7.33M Buy
+160,600
New +$6.96M 0.03% 603

Other funds holding STJ

Timber Hill's STJ Position: Q1 2017 in Review

Timber Hill sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 10,226 shares — an estimated $820K sold.

Timber Hill first reported a position in STJ in Q3 2013 and held it in 12 quarters. The position peaked at $5.02M in Q3 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Timber Hill reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Timber Hill sold 10,226 St Jude Medical shares in Q1 2017, an estimated $820K.
  • Timber Hill first reported a position in St Jude Medical in Q3 2013 and held it in 12 quarters.
  • Timber Hill's St Jude Medical position peaked at $5.02M in Q3 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Timber Hill's 13F filing for Q1 2017, filed 10 May 2017.